Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FFL7N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,663
Award facts
- Contract value 100% obligated
- $23,662.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,662.97 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 29, 2026, with an ultimate completion date of January 30, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The award was issued under AmerisourceBergen's parent company, Cencora, Inc., which maintains a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999.99 million through December 31, 2031. The pharmaceutical supplies will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters.
This delivery order represents a routine procurement of a diabetes medication supporting the Defense Health Agency and broader military healthcare system. AmerisourceBergen, operating under its parent entity Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, and medical devices to support military treatment facilities and veterans' healthcare programs worldwide. The competitively awarded status of this order reflects AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements through open competition on an ongoing basis.
Quick answers
Who was awarded contract SPE2DR26FFL7N?
SPE2DR26FFL7N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FFL7N worth?
The government has obligated $23,663 on SPE2DR26FFL7N.
Is contract SPE2DR26FFL7N an order under another contract?
Yes. SPE2DR26FFL7N is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL7N competed?
The extent of competition for SPE2DR26FFL7N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award